Reading path
Reading the Evidence in Women's Health
Much of medicine was studied first in men, and that history still shapes how trials, drug doses, and screening advice reach women today. This path walks you through real appraisals so you can spot when a study population may not fit the patient, tell a treatment claim from a prevention claim, and read risk numbers in reproductive and menopausal care without being swayed by the framing. By the end you will read women's health evidence with a clearer eye for what it does and does not establish.
The path, step by step
Start here to understand how women came to be under-represented in research, because that history is the backdrop for almost every gap the rest of the path examines.
2 Sex Differences in How Drugs Work: The Ambien Dosing Story as Example and Cautionary Tale
4 min readA single vivid dosing story shows what under-representation actually costs, turning an abstract gap into a concrete reason to check who a drug was tested on.
This gives you the reading tool the theme demands, a way to ask whether a study's population is close enough to the patient in front of you for its results to carry over.
Reproductive care is where alarming headlines and reassuring ones often describe the same data, so this teaches you to separate relative from absolute risk before you react.
5 Reading the Women's Health Initiative Twenty Years On: Why When You Start Reframed the Debate
5 min readThe largest women's health trial has been reread for decades, and following that reappraisal shows how the same result can mean different things depending on who was studied and when treatment began.
Pregnancy is one of medicine's thinnest evidence bases, and here you see how a single trial and a screening-based recommendation get reconciled into practical guidance.
This moves you into screening by working through a randomized trial, showing what a supplemental test does and does not prove after a dense-breast notice.
Agreement and accuracy studies are a different kind of evidence than an outcomes trial, and this shows how they let a screening option expand access without lowering the bar.
9 Why Endometriosis Takes Years to Diagnose
4 min readEnd on the harder nuance of diagnostic delay, where the evidence gap is not one trial but a whole pattern of how a condition gets studied and recognized.
Each step is a full article on the Reading the Evidence blog.